INDICATION SELECTION COMMERCIALIZATION STRATEGY
Situation: Company was in need of competitive intelligence, scientific feasibility insight, and strategic commercial planning using their novel technology.
Activity: Worked directly with the internal team to synthesize existing competitive intelligence. Performed independent literature review and synthesis, competitor pipeline analysis, disease area strategy, and estimated total commercial potential. Collated research and analytic processes, provided deep insights on clinical, biological, and competitive risk; presented to C-suite and internal stakeholders.
Result: Identified top three disease indications and associated antigens to R&D resulting in one antigen/disease indication that is now in Phase 1 clinical development pipeline.